This article examines the mechanism of GLP-1 agonists, their potential risks in Crohn's disease, practical management strategies, and alternative weight management options for patients with inflammatory bowel disease
The expanded benefits and risk of GLP-1 drugs vs other Type 2 diabetes medication from the largest US healthcare system Ziyad Al-Aly Perhaps patients with mental illness comorbid with metabolic diseases might benefit more from GLP-1RAs than from metformin and other antidiabetic medications
Swabs clean injection sites before needle contact occurs
The initial dosage of 40 mcg/kg SC twice daily was increased over time
ultimate multivitamin+ is also GMO-free, gluten-free, dairy-free, soy-free, and free of major food allergens
All of that makes these drugs more expensive, says Laura Davisson, director of the weight management program at the West Virginia University Health System